Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chordoma × Radiotherapy × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gliosarcoma 82 Glioblastoma 80 Sarcoma 73 Central Nervous System Neoplasms 48 Dendritic Cell Sarcoma, Interdigitating 32 Lymphoma 30 Burkitt Lymphoma 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Lymphoma, Non-Hodgkin 25 Lymphoma, Large-Cell, Immunoblastic 25 Lymphoma, Large B-Cell, Diffuse 25 Leukemia 25 Lymphoma, Follicular 23 Lymphoma, Mantle-Cell 22 Myelodysplastic Syndromes 21 Leukemia, Lymphocytic, Chronic, B-Cell 21 Recurrence 20 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Myeloid, Chronic-Phase 20 Hodgkin Disease 19 Astrocytoma 19 Leukemia, Myeloid, Accelerated Phase 18 Multiple Myeloma 17 Leukemia, Myeloid, Acute 17 Blast Crisis 17 Neoplasms, Plasma Cell 15 Glioma 15 Rhabdomyosarcoma 13 Myeloproliferative Disorders 12 Liposarcoma 12

Interventions

Nivolumab 6 Imatinib Mesylate 4 Ipilimumab 3 palbociclib 2 Specimen Handling 2 Radiosurgery 2 Protons 2 Proton Therapy 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 Cetuximab 2 tazemetostat 1 spartalizumab 1 relatlimab 1 pembrolizumab 1 camrelizumab 1 avelumab 1 atezolizumab 1 apatinib 1 Zoledronic Acid 1 X-Rays 1 Tiragolumab 1 Thiotepa 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02383498 2024-05-20

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

NantCell, Inc.

Phase 2 Completed

24 enrolled 8 charts

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡